Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN116425808A details a scalable Gamithromycin method. Offers cost reduction and supply chain reliability for veterinary antibiotics manufacturing.
This patent details a palladium-catalyzed method for heterocyclic compounds offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Efficient palladium-catalyzed carbonylation method for quinoline scaffolds offering cost reduction and supply reliability for pharmaceutical intermediate manufacturing processes.
Patent CN114524701B reveals efficient chiral phosphoric acid catalysis for high-purity pharmaceutical intermediates with superior cytotoxicity against QGP-1 tumor cells.
Novel patent CN115286578B enables metal-free room temperature synthesis. Reduces costs and improves supply chain reliability for pharmaceutical intermediate manufacturing globally.
Novel synthesis route for Finerenone intermediate offering high yield and industrial scalability without heavy metal catalysts.
Novel palladium-catalyzed carbonylation patent CN120208841A offers mild conditions for indene derivatives. Enhances supply chain reliability and reduces manufacturing complexity for global pharmaceutical intermediate suppliers.
Patent CN111732508B details a mild gold-catalyzed route to spiro compounds via C-H functionalization, offering cost-effective manufacturing solutions.
Patent CN101967075A details a mild inorganic base method for terminal alkyne synthesis, offering cost reduction and scalable supply chain solutions for pharma intermediates.
Patent CN112759595B details a novel Pd-catalyzed asymmetric allylation for chiral nucleosides, offering high enantioselectivity and streamlined manufacturing for pharmaceutical intermediates.
Novel Pd-catalyzed one-pot method for high-purity fused heterocycles. Reduces cost and improves supply chain reliability for pharmaceutical intermediates.
Patent CN118754854A reveals efficient Pd-catalyzed tandem reaction for quinolinone derivatives. Reduces steps and improves supply chain reliability for pharmaceutical intermediates.
Patent CN111925308B reveals a mild iridium-catalyzed photocatalytic route for N-substituted sulfone diimines, offering reliable pharmaceutical intermediate supply chains.
Patent CN115353511A details a novel multi-component synthesis of carbonyl-bridged biheterocycles, offering cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN115286629B details a magnetic catalytic route for high-purity pharmaceutical intermediates, offering significant cost reduction and scalable production capabilities.
Novel chiral phosphoric acid catalyzed synthesis of N-N axis pyrroles. High yield, mild conditions, scalable for pharma intermediates.
Patent CN115286628B reveals a Pd-catalyzed carbonylation route. Offers cost reduction and scalable manufacturing for high-purity intermediates.
Advanced oxiracetam synthesis patent analysis offering cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel glucose-based route for triazole intermediates. Reduces cost and simplifies supply chain for pharmaceutical intermediates manufacturing significantly with biomass.
Patent CN112538054B reveals a novel Pd-catalyzed carbonylation route for 1,2,4-triazole-3-ones, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.